Is Lululemon Athletica Gaining or Losing Market Support? - Lululemon Athletica ( NASDAQ:LULU )
Lululemon Athletica's LULU short percent of float has fallen 7.92% since its last report. The company recently reported that it has 5.94 million shares sold short, which is 6.74% of all regular shares that are available for trading.
Bitcoin price rebounds to $108K as millionaire whale goes 20x long on BTC
Analysts say Bitcoin could break its all-time high within 1-2 weeks, following breakout patterns seen recently in gold and the S&P 500.
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Provident Bancorp, Inc. ( NASDAQ: PVBC )
NEW YORK, June 09, 2025 ( GLOBE NEWSWIRE ) -- Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
DEADLINE ALERT for CAR, NSSC, LPRO, and CIVI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Avis Budget Gr ( NASDAQ:CAR ) , Civitas Resources ( NYSE:CIVI )
LOS ANGELES, June 09, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
US Listed Chinese Stocks Gain As US-China Trade Talks Spark Optimism - Alibaba Gr Hldgs ( NYSE:BABA ) , Boeing ( NYSE:BA )
U.S.-listed Chinese stocks rise as trade talks in London focus on rare earths and export approvals spark investor optimism. UBS cites tariff pause, AI buzz, and stimulus hopes as drivers of renewed interest in undervalued China equities.
Analyst Says NewAmsterdam Stock Has Over 100% Upside, Citing 90% Success Probability For Obicetrapib - NewAmsterdam Pharma Co ( NASDAQ:NAMS )
Obicetrapib reduced LDL-C by 33% over 84 days in the Broadway Phase 3 study, meeting the trial's primary endpoint. Analysts project 90% success probability for obicetrapib; Alzheimer's biomarker data adds possible upside. Get access to the leaderboards pointing to tomorrow's biggest stock movers.
Tesla 'Remains The Most Undervalued AI Play': Dan Ives - Tesla ( NASDAQ:TSLA )
Wedbush maintains a Buy rating and $500 price target on Tesla stock. "Tesla remains the most undervalued AI play in the market today," Wedbush's Dan Ives says. Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings-Live With Chris Capre on Wednesday, June 11.
NVIDIA Tests New Resistance - Could Another Breakout Be Brewing? - NVIDIA ( NASDAQ:NVDA )
NVIDIA tests $141.50 resistance, signaling potential breakout and bullish momentum ahead. Supply-demand imbalance favors buyers, indicating upward pressure on NVIDIA's share price. Get access to the leaderboards pointing to tomorrow's biggest stock movers.
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Vertiv Holdings ( NYSE:VRT )
Vertiv Holdings VRT has outperformed the market over the past 5 years by 37.09% on an annualized basis producing an average annual return of 51.6%. Currently, Vertiv Holdings has a market capitalization of $43.52 billion.
Record Market Highs Possible This Week? Key Catalysts: Apple, China, Inflation
Earnings season is nearly wrapped up, but a few notable reports are still on deck this week. The three I'm watching are Oracle, Adobe, and RH. Oracle and Adobe will provide further insight into the tech sector, while RH will offer a glimpse into the high-end consumer space.








